###begin article-title 0
A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury
###end article-title 0
###begin p 1
Conceived and designed the experiments: BS ABM ACU LSA AO. Performed the experiments: BS ABM ACU LSA. Analyzed the data: BS ABM ACU AO. Contributed reagents/materials/analysis tools: BS LSA AmR MJV MO AC JE RS MRO MLC JE EPP AO. Wrote the paper: BS ABM ACU MJV MRO EPP AO.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Inflammation may lead to tissue injury. We have studied the modulation of inflammatory milieu-induced tissue injury, as exemplified by the mesothelium. Peritoneal dialysis is complicated by peritonitis episodes that cause loss of mesothelium. Proinflammatory cytokines are increased in the peritoneal cavity during peritonitis episodes. However there is scarce information on the modulation of cell death by combinations of cytokines and on the therapeutic targets to prevent desmesothelization.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 183 192 183 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 183 192 <span type="species:ncbi:1280">S. aureus</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
Human mesothelial cells were cultured from effluents of stable peritoneal dialysis patients and from omentum of non-dialysis patients. Mesothelial cell death was studied in mice with S. aureus peritonitis and in mice injected with tumor necrosis factor alpha and interferon gamma.
###end p 5
###begin p 6
###xml 823 827 <span type="species:ncbi:10090">mice</span>
Tumor necrosis factor alpha and interferon gamma alone do not induce apoptosis in cultured mesothelial cells. By contrast, the cytokine combination increased the rate of apoptosis 2 to 3-fold over control. Cell death was associated with the activation of caspases and a pancaspase inhibitor prevented apoptosis. Specific caspase-8 and caspase-3 inhibitors were similarly effective. Co-incubation with both cytokines also impaired mesothelial wound healing in an in vitro model. However, inhibition of caspases did not improve wound healing and even impaired the long-term recovery from injury. By contrast, a polymeric nanoconjugate Apaf-1 inhibitor protected from apoptosis and allowed wound healing and long-term recovery. The Apaf-1 inhibitor also protected mesothelial cells from inflammation-induced injury in vivo in mice.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Cooperation between tumor necrosis factor alpha and interferon gamma contributes to mesothelial injury and impairs the regenerative capacity of the monolayer. Caspase inhibition attenuates mesothelial cell apoptosis but does not facilitate regeneration. A drug targeting Apaf-1 allows protection from apoptosis as well as regeneration in the course of inflammation-induced tissue injury.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Heimburger1">[1]</xref>
###xml 597 600 597 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Piraino1">[2]</xref>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Di1">[3]</xref>
###xml 780 783 780 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Verger1">[4]</xref>
###xml 974 977 974 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Chen1">[5]</xref>
###xml 978 981 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Santamaria1">[7]</xref>
###xml 1158 1161 1158 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Baker1">[8]</xref>
###xml 1249 1252 1249 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Chen1">[5]</xref>
###xml 1254 1257 1254 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 1259 1262 1259 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz1">[9]</xref>
###xml 1263 1267 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Heath1">[11]</xref>
###xml 1319 1322 1319 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 1400 1403 1400 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 1562 1566 1562 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Janes1">[12]</xref>
###xml 1855 1858 1855 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Santamaria1">[7]</xref>
###xml 1860 1864 1860 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Heath1">[11]</xref>
###xml 1866 1870 1866 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Broaddus1">[13]</xref>
###xml 1871 1875 1871 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-HaslingerLoffler1">[18]</xref>
###xml 862 870 <span type="species:ncbi:9606">patients</span>
Tissue injury is an unwanted adverse effect of inflammation. Peritoneal dialysis (PD) is a renal replacement therapy modality that is marred by episodes of bacterial infection, leading to localized inflammation evidenced as peritonitis [1]. PD represents an interesting model of inflammation since the technique consists of and allows repeated non-invasive access to the peritoneal cavity, allowing both monitoring of the inflammatory process as well as therapy by local delivery of drugs. Currently the therapy of peritonitis consists of local intraperitoneal delivery of antibiotics and heparin [2]. One of the main peritoneal manifestations of inflammatory tissue injury is loss of mesothelial cells, which occurs both during chronic PD and in acute inflammatory episodes [3], [4]. Apoptotic mesothelial cells are lost in the peritoneal effluent of stable PD patients and the number of peritoneal effluent apoptotic mesothelial cells increases 80-fold during peritonitis [5]-[7]. Counting effluent apoptotic cells will underestimate apoptosis, since the apoptotic features have a half-life of 1-2 hours and most apoptotic cells are engulfed by phagocytes [8]. Lethal cytokines are among the endogenous mediators that cause mesothelial cell death [5], [6], [9]-[11]. FasL directly promotes mesothelial cell apoptosis [6]. By contrast, neither TNF nor TRAIL alone modulate mesothelial cell survival [6]. However, most extracellular inputs are not processed in isolation, rather, multiple inputs are perceived and integrated by cells in a proinflammatory milieu [12]. In this regard, mesothelial cells are immersed in a complex microenvironment and inflammatory cytokines may cooperate to influence on mesothelial cell fate. Other inflammatory mediators, bacterial infection, tumor cells, PD solutions and asbestos also promote mesothelial cell apoptosis [7], [11], [13]-[18].
###end p 10
###begin p 11
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz1">[9]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz2">[19]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Sanz1">[20]</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz1">[9]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz2">[19]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Strasser1">[21]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Sanz1">[20]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz3">[22]</xref>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Li1">[23]</xref>
###xml 1246 1249 1246 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 1251 1255 1251 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan2">[24]</xref>
###xml 1257 1261 1257 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan3">[25]</xref>
###xml 1421 1425 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ben1">[26]</xref>
###xml 1426 1430 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Li2">[28]</xref>
###xml 1595 1599 1595 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo1">[29]</xref>
###xml 2046 2050 2046 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Malet1">[30]</xref>
###xml 2051 2055 2051 2055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lee2">[32]</xref>
###xml 1677 1682 <span type="species:ncbi:9606">human</span>
Apoptosis is an active model of cell death that regulates cell number [9], [19], [20]. Understanding the regulation of apoptosis has possible therapeutic relevance, since it is regulated by the activation of intracellular lethal molecules in response to the cell microenvironment [9], [19]-[21]. Among them, caspases are a family of intracellular cysteine proteases that behave as activators and effectors of apoptosis, and play a central role in the process [20], [22]. Caspase-8 is the canonical initiator caspase engaged by lethal cytokines that activate cell death receptors. In turn, caspase-8 recruits the mitochondrial pathway for apoptosis and activates executioner caspases, such as caspase-3, that are responsible for cell death. Activation of the mitochondrial pathway, leads to the release of proapoptotic molecules such as cytochrome c into the cytoplasm, which, in the presence of dATP, induce the formation of the Apaf-1 (apoptotic protease activating factor 1)-containing macromolecular complex called the apoptosome. This complex, in turn, binds to and activates caspase-9. Mature caspase-9 activates effector caspases [23]. Caspase inhibitors prevent leukocyte apoptosis induced by conventional, glucose-containing PD solutions [6], [24], [25]. However, recent reports have emphasized non-apoptotic functions of caspases including promotion of cell proliferation that contributes to tissue regeneration [26]-[28]. In addition, in certain epithelial cell types, caspase inhibition may transform a mild proapoptotic response into an intense necrotic response to lethal cytokines [29]. We now explore the cooperation between inflammatory cytokines in modulating human mesothelial cell fate and possible therapeutic interventions to prevent mesothelial cell death during inflammation. In particular we have analyzed its modulation by classical caspase inhibitors as well as by targeting the activity of the apoptosome. Recent reports have proposed the apoptosome as an interesting target for the development of apoptosis inhibitors [30]-[32]. Indeed, our results showed that chemical inhibition of apoptosome activity with a nanoconjugate Apaf-1 inhibitor is effective in protecting mesothelial cells from cytokine-induced apoptosis and, in contrast to caspase inhibition, it allows wound healing and long-term recovery.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Regulation of mesothelial cell apoptosis by cooperation of inflammatory cytokines
###end title 13
###begin p 14
###xml 145 148 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Di1">[3]</xref>
###xml 149 152 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 267 271 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Dasgupta1">[33]</xref>
###xml 273 277 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Brauner1">[34]</xref>
###xml 342 346 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz2">[19]</xref>
###xml 490 502 474 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1. A, B</bold>
###xml 490 502 474 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1. A, B</bold></xref>
###xml 544 555 520 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1.A, B</bold>
###xml 544 555 520 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.A, B</bold></xref>
###xml 557 560 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 652 663 628 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1.B, C</bold>
###xml 652 663 628 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.B, C</bold></xref>
###xml 1017 1025 985 993 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1.D</bold>
###xml 1017 1025 985 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.D</bold></xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 398 403 <span type="species:ncbi:9606">human</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
###xml 928 933 <span type="species:ncbi:9606">human</span>
###xml 1007 1015 <span type="species:ncbi:9606">patients</span>
Acute demesothelization occurs during experimental and human peritonitis, and is associated with an increased rate of mesothelial cell apoptosis [3]-[6]. During peritoneal inflammation numerous cytokines are released locally. Among them we find IFNgamma and TNFalpha [33], [34]. Although TNFalpha is, by itself, a potentially lethal cytokine [19], we did not observe a lethal effect of TNFalpha in human peritoneal mesothelial cells (HPMC) cultured from the effluent of stable PD patients (Fig. 1. A, B). IFNgamma increased TNFalpha lethality (Fig. 1.A, B) [6]. The combination of cytokines induced HPMC apoptosis in a time- and dose-dependent manner (Fig. 1.B, C). By contrast, cytokines had no effect on the percentage of cells on the S or M phase of the cell cycle, as assessed by flow cytometry of DNA content (range 9 to 10% for the different conditions). The combination of IFNgamma and TNFalpha also induced apoptosis in human omental mesothelial cells (HOMC) cultured from the omentum of non-uremic patients (Fig. 1.D).
###end p 14
###begin title 15
Cooperation of cytokines induces apoptosis in mesothelial cells.
###end title 15
###begin p 16
A) Representative flow cytometry of DNA content diagrams. Note the increase in the hypodiploid, apoptotic population in HPMC cultured for 48 h in presence of TNFalpha/IFNgamma. B) Quantification of apoptosis in HPMC by flow cytometry. The combination of TNFalpha/IFNgamma induces apoptosis. When not specified, 300 U/mL IFNgamma and 250 ng/mL TNFalpha were used, * p<0.04 vs each individual cytokine at 24 h. ** p<0.001 vs each individual cytokine at 48 h. & p<0.001 vs control. Mean+/-SEM of 6 different experiments. C) Dose-response in HPMC. Mean+/-SEM of 4 different experiments * p<0.05 vs control. D) Quantification of apoptosis in HOMC by flow cytometry. The combination TNFalpha/IFNgamma for 48 h induces apoptosis. *p<0.005 vs. control. Mean+/-SEM of 4 different experiments.
###end p 16
###begin title 17
Caspases mediate mesothelial cell apoptosis induced by cytokine cooperation
###end title 17
###begin p 18
###xml 255 263 247 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2.A</bold>
###xml 255 263 247 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A</bold></xref>
###xml 408 416 392 400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2.B</bold>
###xml 408 416 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.B</bold></xref>
###xml 933 941 915 923 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2.A</bold>
###xml 933 941 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A</bold></xref>
###xml 987 997 969 979 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2.A&#8211;C</bold>
###xml 987 997 969 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A&#8211;C</bold></xref>
###xml 1074 1085 1056 1067 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2.D, E</bold>
###xml 1074 1085 1056 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.D, E</bold></xref>
###xml 1477 1481 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo1">[29]</xref>
###xml 1510 1516 1484 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
HPMC apoptosis induced by TNFalpha and IFNgamma was characterized by the appearance of caspase-generated fragments of cytokeratin 8/18 in the cytoplasm and typical morphological features of nuclear apoptosis, such as shrunk, bright and fragmented nuclei (Fig. 2.A). Flow cytometry confirmed that TNFalpha and IFNgamma increased the number of cells containing caspase-generated fragments of cytokeratin 8/18 (Fig. 2.B) and caspase-3 activity was increased by 1.7+/-0.4 fold over control at 24 h in a colorimetric assay (p<0.02, not shown). Taken together, these data provide evidence for the involvement of caspases in the process. In order to confirm the requirement for caspases and to explore possible therapeutic strategies, cells were treated with caspase inhibitors. The pan-caspase inhibitor, zVAD, or specific caspase-3 (DEVD) or caspase-8 (IETD) inhibitors prevented morphological features of apoptosis induced by cytokines (Fig. 2.A) and the activation of executioner caspases (Fig. 2.A-C), and decreased apoptosis as assessed by the presence of hypodiploid cells (Fig. 2.D, E). Similar results were obtained in HOMC (not shown). The most effective caspase inhibitor in decreasing the rate of apoptosis, zVAD, was studied in further detail. In mesothelial cells exposed to TNFalpha and IFNgamma, zVAD was unable to prevent eventual cell death (data not shown) despite not increasing the non-apoptotic cytotoxicity of cytokines, as it is the case with other cell types [29]. Caspase inhibition was not per se toxic in cells not exposed to cytokine combinations and did not increase the number of dead cells staining with trypan blue (data not shown).
###end p 18
###begin title 19
Apoptosis induced by cooperation of cytokines is caspase-dependent.
###end title 19
###begin p 20
A) Caspase activation in HPMC exposed to TNFalpha/IFNgamma for 24 h. Apoptosis was decreased by zVAD (pan-caspase inhibitor), DEVD (caspase-3 inhibitor) and IETD (caspase-8 inhibitor). Note cytokeratin (CK) 8/18 cleavage by caspases as well as the nuclear apoptotic morphology in cells exposed to TNFalpha/IFNgamma (arrowheads). Green: FITC-M30 cytodeath antibody, red: propidium iodide in permeabilized cells. Original magnification x100. B) Representative diagram of detection of caspase-cleaved CK 8/18 by flow cytometry in HPMC. C) Quantification of caspase-cleaved CK 8/18 by flow cytometry in HPMC treated with TNFalpha and IFNgamma for 24 h. * p<0.005 vs control and # p<0.05 vs TNFalpha/IFNgamma. Mean+/-SEM of 4 different experiments. D) Flow cytometry diagrams of permeabilized, propidium iodide-stained cells. Note the decrement of hypodiploid cells (arrowhead) in the presence of caspase inhibitors in HPMC. E) Quantification of apoptosis by flow cytometry of DNA content in HPMC exposed to TNFalpha/IFNgamma for 48 h. Apoptosis was decreased by zVAD, DEVD and IETD. *p<0.001 vs control and # p<0.0005 vs TNFalpha/IFNgamma. Mean+/-SEM of 6 independent experiments.
###end p 20
###begin title 21
Impaired wound healing in the presence of a proinflammatory milieu is not rescued by caspase inhibition
###end title 21
###begin p 22
###xml 487 498 487 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3.A, B</bold>
###xml 487 498 487 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g003"><bold>Fig. 3.A, B</bold></xref>
###xml 746 757 730 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3.A, B</bold>
###xml 746 757 730 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g003"><bold>Fig. 3.A, B</bold></xref>
Acute demesothelization during peritonitis, unless very severe, is usually a reversible response, and mesothelial cells later repopulate the denuded area. In a wound healing system of HPMC we studied recovery from injury in the absence of exogenous survival factors, aiming to reproduce the adverse microenvironmental conditions of the inflamed peritoneum. Under control conditions, in the absence of proinflammatory cytokines, the mesothelial covering of the wound increased over 48 h (Fig. 3.A, B). Caspase inhibition tended to stall the process at late time points. The continuous presence of TNFalpha and IFNgamma prevented wound healing. Inhibition of caspases by zVAD did not rescue wound healing among cells treated TNFalpha and IFNgamma (Fig. 3.A, B). IETD and DEVD caspase inhibitors offered no advantage over zVAD (not shown).
###end p 22
###begin title 23
Inflammatory cytokines retard remesothelization.
###end title 23
###begin p 24
###xml 312 313 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A) Wound healing in HPMC. Contrast phase microscopy. Cells were preincubated with caspase inhibitor or vehicle and cultured in presence of proinflammatory TNFalpha/IFNgamma or control media. Original magnification 20x. B) Quantification of wound healing as number of HPMC cells filling the denuded area (cells/mm2). In presence of cytokines there is delayed wound healing that is not improved by zVAD.* p<0.03 control vs. TNFalpha/IFNgamma and control vs TNFalpha/IFNgamma/zVAD. Mean+/-SEM of 5 different experiments.
###end p 24
###begin title 25
A nanoconjugate Apaf-1 inhibitor prevents cytokine-induced apoptosis and promotes wound healing
###end title 25
###begin p 26
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Malet1">[30]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lee2">[32]</xref>
###xml 368 376 368 376 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4.A</bold>
###xml 368 376 368 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.A</bold></xref>
###xml 511 519 503 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4.A</bold>
###xml 511 519 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.A</bold></xref>
###xml 629 637 621 629 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4.B</bold>
###xml 629 637 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.B</bold></xref>
###xml 997 1007 953 963 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4.C,D</bold>
###xml 997 1007 953 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.C,D</bold></xref>
###xml 1259 1270 1215 1226 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5.A, B</bold>
###xml 1259 1270 1215 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g005"><bold>Fig. 5.A, B</bold></xref>
Formation of the apoptosome is a key event in the apoptotic signaling pathway. First-in-class polyglutamic acid (PGA)-based Apaf-1 inhibitor nanoconjugates (PGA-peptoids) are well suited for in vivo applications [30]-[32]. The PGA-peptoid QM56 prevented, in a dose-dependent manner, mesothelial cell apoptosis induced by a combination of cytokines, as shown for HOMC (Fig. 4.A). The QM56 concentration chosen for the rest of the experiments (10 microM) had an antiapoptotic activity similar to 200 microM zVAD (Fig. 4.A). In cultured mesothelial cells QM56 prevented caspase-3 processing induced by cytokines, as shown for HOMC (Fig. 4.B) and completely prevented the increase in caspase 3 activity induced by TNFalpha/IFNgamma in these cells (TNFalpha/IFNgamma 1,7+/-0.4 vs TNFalpha/IFNgamma/QM56 0,56+/-0.18 fold over control, p<0.03, not shown). Similar to observations with caspase inhibitors, QM56 prevented apoptosis induced by TNFalpha and IFNgamma in mesothelial cells, as shown for HPMC (Fig. 4.C,D). QM56 did not modify the percentage of cells in the S+M phases of the cell cycle (not shown). By contrast to classical caspase inhibitors, QM56 restored the wound healing capacity of mesothelial cells in the presence of cytokines, as shown for HPMC (Fig. 5.A, B).
###end p 26
###begin title 27
A nanoconjugate Apaf-1 inhibitor (PGA-peptoid QM56) inhibits caspase activation and apoptosis.
###end title 27
###begin p 28
###xml 519 523 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Slee1">[73]</xref>
###xml 525 529 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Polverino1">[74]</xref>
###xml 596 600 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Polverino1">[74]</xref>
A) Quantification of apoptosis in HOMC by flow cytometry. HOMC were preincubated with different concentrations of inhibitors or vehicle and cultured with TNFalpha and IFNgamma for 48 hours. Mean+/-SEM of 3 different experiments *p<0.001vs TNFalpha/IFNgamma. B) QM56 prevents procaspase-3 processing and the appearance of active p17 and p19 caspase-3 fragments 24 h following exposure to TNFalpha/IFNgamma in HOMC. zVAD stalled the process of caspase activation at the level of the p21 precursor as previously described [73], [74]. Binding of zVAD.fmk to this p21 intermediate blocks its activity [74]. Western blot, representative of 3 independent experiments. C) Representative flow cytometry of DNA content diagrams. Cells were preincubated with QM56 and then cultured with TNFalpha/IFNgamma for 48 h. Note the decreased number of hypodiploid apoptotic HPMC in TNFalpha/IFNgamma/QM56 treated cells (black arrow). Inset: nuclear apoptotic morphology in cells exposed to TNFalpha/IFNgamma and stained with DAPI (white arrows). D) Quantification of apoptosis by flow cytometry of DNA content in HPMC. Mean+/-SEM of 6 different experiments. *p<0.002 vs cells treated with TNFalpha/IFNgamma/QM56.
###end p 28
###begin title 29
QM56 preserves remesothelization.
###end title 29
###begin p 30
###xml 299 300 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A) Wound healing in HPMC. Contrast phase microscopy. Cells were preincubated with Apaf-1 inhibitor and cultured in presence of proinflammatory medium (TNFalpha and IFNgamma). Original magnification 20x. B) Quantification of wound healing in HPMC as number of cells filling the denuded area (cells/mm2). The delayed wound healing induced by TNFalpha/IFNgamma is recovered in presence of QM56. * p<0.03 control vs. TNFalpha/IFNgamma ** p<0.003 TNFalpha/IFNgamma/QM56 vs. TNFalpha/IFNgamma. Mean+/-SEM of 5 different experiments.
###end p 30
###begin title 31
Apaf-1 inhibition, but not caspase inhibition, improves long-term recovery from inflammatory injury
###end title 31
###begin p 32
###xml 814 822 798 806 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6.A</bold>
###xml 814 822 798 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.A</bold></xref>
###xml 983 991 967 975 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6.A</bold>
###xml 983 991 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.A</bold></xref>
###xml 1060 1070 1044 1054 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6.B,C</bold>
###xml 1060 1070 1044 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.B,C</bold></xref>
###xml 1216 1224 1200 1208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6.C</bold>
###xml 1216 1224 1200 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.C</bold></xref>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 1050 1058 <span type="species:ncbi:9606">patients</span>
We next explored the potential long-term consequences of caspase inhibition in the context of transient, short-term inflammation. Cells were cultured for 24 to 48 h in the presence of TNFalpha and IFNgamma with or without inhibitors and then trypsinized, seeded in new plaques and left to recover for 5 days in the presence of survival factors from serum but in the absence of cytokines or inhibitors. This mimics intraperitoneal events during the recovery from human peritonitis with an adequate response to antibiotics. Despite the acute increase in cell death and delayed wound healing observed in the presence of TNFalpha and IFNgamma, the removal of these cytokines from the media and the addition of exogenous survival factors was associated with a degree of recovery close to that obtained in control HPMC (Fig. 6.A). The initial presence of the cytokine combination and the pan-caspase inhibitor led to a reduced final cell number, suggesting loss of regenerative potential (Fig. 6.A). Similar results were observed in HOMC from non-dialysis patients (Fig. 6.B,C). Short-term exposure of control cells to zVAD did not impair long-term recovery, indicating that this is not an intrinsic toxic effect of zVAD (Fig. 6.C).
###end p 32
###begin title 33
Caspase inhibition compromises long-term recovery from inflammatory injury while Apaf-1 inhibition does not.
###end title 33
###begin p 34
A) HPMC plated on twelve-well plates were preincubated with inhibitors or vehicle and exposed to TNFalpha/IFNgamma for 24 h. Cells were then trypsinized, washed, and seeded in Petri dishes in the presence of complete medium with 20% FCS for 5 days, but without cytokines or inhibitors, to allow for their recovery. Cells were stained with crystal violet after 5 days. Representative of 3 different experiments. B) Similar results were obtained with HOMC. HOMC were preincubated with inhibitors or vehicle and exposed to TNFalpha/IFNgamma for 48 h. Then the cells were trypsinized, washed and seeded without inhibitors and cytokines for 5 days. Representative of 4 different experiments. C) Quantification of crystal violet staining in HOMC. Mean+/-SEM of 4 different experiments. *p<0.03 vs TNFalpha/IFNgamma; #p<0.02 vs TNFalpha/IFNgamma.
###end p 34
###begin p 35
###xml 135 144 135 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A&#8211;C</bold>
###xml 135 144 135 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6A&#8211;C</bold></xref>
###xml 193 201 193 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6.C</bold>
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.C</bold></xref>
By contrast to caspase inhibition, QM56 did not impair the long-term regeneration of HPMC or HOMC subjected to an inflammatory milieu (Fig. 6A-C). Indeed, QM56 significantly improved recovery (Fig. 6.C).
###end p 35
###begin title 36
Apaf-1 inhibitor protects from inflammation-induced apoptosis in vivo
###end title 36
###begin p 37
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Santamaria1">[7]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Rosenblatt1">[35]</xref>
###xml 430 436 422 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7</bold>
###xml 430 436 422 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g007"><bold>Fig. 7</bold></xref>
###xml 439 448 431 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 506 512 498 504 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 8</bold>
###xml 506 512 498 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g008"><bold>Fig. 8</bold></xref>
###xml 625 631 617 623 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7</bold>
###xml 625 631 617 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g007"><bold>Fig. 7</bold></xref>
###xml 631 632 623 624 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 632 633 624 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</bold>
###xml 632 633 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006634-g008"><bold>8</bold></xref>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 439 448 <span type="species:ncbi:1280">S. aureus</span>
We next explored the potential of QM56 to modulate cell injury in vivo. Cytokeratin fragmentation, a marker of apoptosis that precedes nuclear changes [7], was chosen because in vivo early apoptotic cells are rapidly expelled from cell monolayers and engulfed by professional phagocytes [35]. In mice the intraperitoneal administration of TNFalpha and IFNgamma resulted in an increased rate of mesothelial cell apoptosis at 48 h (Fig. 7). S. aureus peritonitis also resulted in mesothelial cell apoptosis (Fig. 8). The Apaf-1 inhibitor QM56 prevented mesothelial cells apoptosis induced by both inflammatory milieus in vivo (Fig. 7,8).
###end p 37
###begin title 38
QM56 prevents mesothelial cell apoptosis induced by intraperitoneal cytokine administration in vivo.
###end title 38
###begin p 39
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Mice were injected ip with 250 ng/mL TNFalpha and 300 U/mL IFNgamma at time 0 and sacrificed at 48 h. QM56 or vehicle was administrated 1 h before the cytokines and 5 h later. A) Representative images of Cytodeath (green)/propidium iodide co-staining. Note an increased number of cells with green cytoplasm indicative of caspase-mediated apoptosis in the sample from the mouse injected with TNFalpha/IFNgamma. Magnification x120 B) Quantification of positive cells (green) using Image Pro plus software in 5 fields per mouse (around 600 cells). Mean+/-SEM of 5 mice per group. * p<0.001 vs. control: # p<0.001vs.TNFalpha IFNgamma.
###end p 39
###begin title 40
###xml 48 57 48 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 48 57 <span type="species:ncbi:1280">S. aureus</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
QM56 prevents mesothelial cell apoptosis during S. aureus peritonitis in mice.
###end title 40
###begin p 41
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 134 143 134 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 382 391 382 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 41 50 <span type="species:ncbi:1280">S. aureus</span>
###xml 134 143 <span type="species:ncbi:1280">S. aureus</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 382 391 <span type="species:ncbi:1280">S. aureus</span>
###xml 545 550 <span type="species:ncbi:10090">mouse</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
Mice were injected ip. with 5x108 c.f.u. S. aureus at time 0 and sacrificed at 48 h. QM56 or vehicle was administrated 1 h before the S. aureus and 5 h later A) Representative images of Cytodeath (green)/propidium iodide co-staining. Note an increased number of cells with green cytoplasm (arrows) indicative of caspase-mediated apoptosis in the sample from the mouse injected with S. aureus. Apoptosis was prevented by QM56 Magnification x120. B) Quantification of cytodeath positive cells (green) using Image Pro plus software in 5 fields per mouse (around 600 cells). Mean+/-SEM of 5 mice per group. * p<0.05 vs control.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 417 425 <span type="species:ncbi:9606">patients</span>
We chose mesothelial cell injury as a model for inflammation-induced tissue injury because mesothelial cell loss is a clinical problem in PD. In addition, the easy access to the peritoneal cavity allows the local delivery of therapeutic agents. We now report that in inflammation-induced mesothelial cell injury cytokines cooperate to induce apoptosis in primary cultures of mesothelial cells obtained from either PD patients or non-uremic individuals. We have further explored possible therapeutic strategies to prevent cell injury and have identified Apaf-1 inhibition as a novel approach that prevents acute inflammation-induced mesothelial cell injury and allows recovery.
###end p 43
###begin p 44
###xml 88 91 88 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Chen1">[5]</xref>
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Santamaria1">[7]</xref>
###xml 319 323 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Dasgupta1">[33]</xref>
###xml 325 329 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Brauner1">[34]</xref>
###xml 331 335 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Zemel1">[36]</xref>
###xml 337 341 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-McLoughlin1">[37]</xref>
###xml 485 494 469 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 651 655 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Dasgupta1">[33]</xref>
###xml 657 661 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Brauner1">[34]</xref>
###xml 798 802 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Janes1">[12]</xref>
###xml 1196 1200 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Crum1">[38]</xref>
###xml 1279 1283 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Crum1">[38]</xref>
###xml 1283 1287 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Saliu1">[39]</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 485 494 <span type="species:ncbi:1280">S. aureus</span>
Mesothelial cells are lost by apoptosis in the course of human bacterial PD peritonitis [5]-[7]. We now observed an increased mesothelial apoptosis rate in an experimental model of bacterial peritonitis. In the course of peritonitis multiple inflammatory mediators are released locally, including IFNgamma and TNFalpha [33], [34], [36], [37]. Interestingly, the highest peritoneal IFNgamma and TNFalpha levels are found in peritonitis caused by highly virulent microorganisms, such as S. aureus, precisely the ones that cause more severe demesothelization and that may lead to irreversible peritoneal injury after a single, severe peritonitis episode [33], [34]. Since multiple inputs are perceived by cells in a proinflammatory milieu, it is relevant to study the actions of cytokine combinations [12]. Our studies show that a TNFalpha/IFNgamma combination promoted apoptosis of cultured mesothelial cells, and explore novel therapeutic approaches to prevent inflammation-induced tissue injury that do not target TNFalpha or IFNgamma. Both TNFalpha and IFNgamma are required for an effective antibacterial defense. TNFalpha antagonists have been marred by an increased rate of severe infections [38]. This is more obvious with infliximab, which also inhibits IFNgamma secretion [38][39]. This suggests that during infection rather than antagonize cytokines, we should strive for the selective therapeutic manipulation of their specific adverse effects that promote tissue injury, such as parenchymal cell apoptosis.
###end p 44
###begin p 45
###xml 1548 1552 1548 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Janes1">[12]</xref>
###xml 1554 1558 1554 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo1">[29]</xref>
###xml 1560 1564 1560 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Vercammen1">[40]</xref>
###xml 1982 1986 1966 1970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Yi1">[41]</xref>
###xml 2061 2065 2045 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Haider1">[42]</xref>
###xml 2205 2209 2189 2193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ben1">[26]</xref>
###xml 2210 2214 2194 2198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Li2">[28]</xref>
###xml 2216 2220 2200 2204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Kondo1">[43]</xref>
###xml 2222 2226 2206 2210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Wells1">[44]</xref>
###xml 2343 2347 2323 2327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ding1">[45]</xref>
###xml 2349 2353 2329 2333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Bradham1">[46]</xref>
###xml 2541 2545 2517 2521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ben1">[26]</xref>
###xml 2547 2551 2523 2527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Yamada1">[47]</xref>
###xml 2553 2557 2529 2533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Webber1">[48]</xref>
###xml 2612 2616 2588 2592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Zhao1">[27]</xref>
###xml 2618 2622 2594 2598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Li2">[28]</xref>
A single episode of very severe peritonitis may cause irreversible demesothelization and peritoneal fibrosis. However, more often peritonitis is mild to severe, and is followed by partial or total recovery of mesothelial integrity. Both the magnitude of the initial acute loss of mesothelium and the ability of cells to regenerate are important factors in the recovery phase. Our experimental design has addressed how therapeutic agents modulate the initial lethal response to inflammation, the subsequent ability of the mesothelium to repopulate a demesothelized area in the presence of ongoing adverse microenvironmental conditions, and the later recovery phase taking place under a milder microenvironment. The continuous presence of inflammatory cytokines increased the rate of apoptosis and impaired regeneration of the mesothelial layer. However, restoration of the normal cell milieu, with disappearance of inflammatory cytokines and the renewed presence of survival factors, lead to recovery. We now show that cytokine-mediated mesothelial cell apoptosis depends on caspase activation and is prevented by caspase inhibition. However, caspase inhibition did not allow mesothelial layer regeneration in the presence of cytokines to proceed, and, more ominously, severely impaired the long-term regeneration of the mesothelium once cytokines were removed. There are several possible explanations for this phenomenon. First, massive induction of necrosis may occur in cells exposed to members of the TNF superfamily when caspases are inhibited [12], [29], [40]. In this regard, caspase inhibitors did not transform a moderate degree of mesothelial cell apoptosis into a catastrophic rate of necrosis, as zVAD/TNFalpha/IFNgamma did not increase the percentage of necrotic cells over TNFalpha/IFNgamma. However, caspase inhibition may not prevent eventual non-apoptotic death in cells rescued from apoptosis. Second, caspase inhibitors may inhibit non-apoptotic roles of caspases [41]. Cell migration and mitosis are required to repair a cell monolayer wound [42]. Recently a spate of non-apoptotic caspase actions on cell proliferation and migration have been described that favor the recovery process [26]-[28], [43], [44]. As an example, TNFalpha is deleterious for the liver in the course of inflammation, through induction of apoptosis [45], [46]. However, liver regeneration following partial hepatectomy requires TNFalpha signaling through the TNFR-1 receptor and caspase-8 activation that primes hepatocytes to respond to mitogens [26], [47], [48]. Caspase-3 and caspase- 11 may promote cell migration [27], [28].
###end p 45
###begin p 46
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Malet1">[30]</xref>
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Vicent1">[31]</xref>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Mondragon1">[49]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Chen2">[50]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ashkenazi1">[53]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Bao1">[54]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Franklin1">[56]</xref>
###xml 1469 1476 1469 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1481 1489 1481 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1669 1673 1669 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Gdynia1">[57]</xref>
###xml 1816 1820 1816 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Gdynia1">[57]</xref>
###xml 2031 2035 2031 2035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Zermati1">[58]</xref>
###xml 2268 2272 2268 2272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Cecconi1">[59]</xref>
###xml 2274 2278 2274 2278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Yoshida1">[60]</xref>
###xml 2448 2452 2448 2452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Mondragon1">[49]</xref>
###xml 2800 2804 2792 2796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Gastaldello1">[16]</xref>
###xml 2806 2810 2798 2802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-HaslingerLoffler1">[18]</xref>
###xml 1398 1403 <span type="species:ncbi:9606">human</span>
###xml 2195 2199 <span type="species:ncbi:10090">mice</span>
###xml 2677 2698 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Chemical inhibition of Apaf-1 by a nanoconjugate molecule [30], [31], [49] prevented mesothelial cell apoptosis induced by the combination of cytokines in cell culture and in vivo, suggesting that Apaf-1 is required for mesothelial cell death to occur. This suggests that mitochondria are engaged during TNF-induced mesothelial cell apoptosis and, thus, that mesothelial cells should be considered type II with regard to their response to death receptor activation [50]-[53]. Following release of cytochrome c from mitochondria, Apaf-1 is required for caspase-9 activation, setting in motion a rapid amplification of the death signal through activation of caspase-3 and downstream caspases leading to further mitochondrial injury [54]-[56]. Contrary to caspase inhibitors, the inhibitor of Apaf-1 also restored the wound healing capacity and promoted long-term recovery of mesothelium. Two, non-mutually exclusive hypothesis, might explain the differences observed between caspase and Apaf-1 inhibitors. In one of them additional functions of caspases, resulting from caspase activation not mediated by proapoptotic stimuli, and, thus, not targeted by inhibition of Apaf-1, may explain the differences. In the previous paragraph we mentioned several non-apoptotic functions of caspases that may not be targeted by the Apaf-1 inhibitor. In addition, as an example, in the absence of cellular stress human glioblastoma cells exhibit a constitutive activation of caspases in vivo and in vitro. Basal caspase 3 and caspase 8 activity promotes migration and invasiveness in glioblastoma cells and inhibition of caspases decreases the migration and the invasiveness of cells [57]. The administration of low doses of caspase inhibitors may block glioma cell motility without affecting the execution of apoptotic cell death [57]. In the second hypothesis, additional functions of Apaf-1 inhibitors, unrelated to caspases, may underlie this observation. For example, inhibition of the recently described cell cycle arrest induced by Apaf-1 [58]. Although the role of Apaf-1 in the DNA damage checkpoint may raise concerns on the carcinogenicity of Apaf-1 targeting, life-long lack of Apaf-1 in Apaf-1-/- mice has not been reported to result in an increased incidence of tumors [59], [60]. Additional actions of the Apaf-1 inhibitor cannot be excluded, since a related compound, in addition to inhibiting both functions of Apaf-1, also protects mitochondria [49]. The therapeutic potential of the Apaf-1 inhibitor was confirmed in vivo, where it prevented mesothelial cell loss induced by either TNFalpha/IFNgamma or by bacterial peritonitis. Certain stimuli, such as osmotic stress and Staphylococcus aureus promote mesothelial cell death with features of apoptosis that is no prevented by caspase inhibitors [16], [18]. It will be interesting to test the efficacy of Apaf-1 inhibitors in preventing cell death in these models.
###end p 46
###begin p 47
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Hubbard1">[61]</xref>
###xml 116 122 <span type="species:ncbi:9606">humans</span>
###xml 448 454 <span type="species:ncbi:9606">humans</span>
In this paper we have focused on the monomicrobial peritonitis characteristic of PD as a proof-of-concept model. In humans these peritonitis are routinely treated by the intraperitoneal administration of therapeutic agents, as used in our models. Polymicrobial peritonitis resulting from visceral perforation, as exemplified by the cecal ligation and puncture model is also a clinically relevant model [61]. However, intravenous therapy is used in humans with perforated bowels, and thus would be the most relevant rout to be studied in animals. This route presents currently unresolved pharmacokinetic issues with the Apaf-1 inhibitor we used. Apaf-1 inhibitors should also be tested in this model in future studies.
###end p 47
###begin p 48
In summary, our data indicate that a chemical compound targeting Apaf-1 prevented inflammation-induced tissue damage, exemplified by the peritoneum, without the adverse consequences of approaches targeting caspases. Our data offer a word of caution when considering the use of caspase inhibitors in the clinical setting: the potential benefits obtained by limiting the initial apoptosis wave may be offset by an impaired recovery from parenchymal cell injury.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
Mesothelial cell cultures
###end title 50
###begin p 51
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan1">[6]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Diaz1">[62]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-YanezMo1">[63]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Stylianou1">[64]</xref>
###xml 125 130 <span type="species:ncbi:9606">Human</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 269 274 <span type="species:ncbi:9606">Human</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
The study was approved by the clinical ethics committee of Fundacion Jimenez Diaz and written informed consent was obtained. Human peritoneal mesothelial cell (HPMC) were cultured from peritoneal effluents from 6 stable CAPD patients as previously described [6], [62]. Human omental mesothelial cells (HOMC) were obtained from omentum from 6 non-PD patients who underwent unrelated elective abdominal surgery [63], [64].
###end p 51
###begin title 52
Reagents
###end title 52
###begin p 53
###xml 128 132 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz3">[22]</xref>
###xml 134 138 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lorz1">[65]</xref>
###xml 258 267 250 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 300 304 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Dasgupta1">[33]</xref>
###xml 306 310 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Brauner1">[34]</xref>
###xml 441 445 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Dasgupta1">[33]</xref>
###xml 447 451 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Brauner1">[34]</xref>
###xml 1106 1110 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Malet1">[30]</xref>
###xml 1112 1116 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Vicent1">[31]</xref>
###xml 1303 1312 1271 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006634.s001">Figure S1</xref>
###xml 1314 1318 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Malet1">[30]</xref>
###xml 1320 1324 1288 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Vicent1">[31]</xref>
###xml 1562 1566 1518 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lorz2">[66]</xref>
###xml 1568 1572 1524 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz4">[67]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 258 267 <span type="species:ncbi:1280">S. aureus</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
###xml 1221 1226 <span type="species:ncbi:9606">human</span>
Human IFNgamma and TNFalpha (Peprotech, London, UK) were used at concentrations based on prior experience with other cell types [22], [65] and expected to occur in vivo during peritonitis, specially in patients infected with highly virulent bacteria such as S. aureus, adjusted for PD fluid dilution [33], [34]. Peritoneal effluent concentrations of 4.5 ng/ml TNFalpha and 45 U/ml IFNgamma have been reported in the effluents of PD patients [33], [34]. Higher cytokine concentrations may be reached locally in mesothelial cells in close contact with paracrine cytokine-secreting leukocytes, as well as in non-PD peritonitis, which lacks the diluting effect of PD solutions. The combination of 100 U/mL (5 ng/mL) TNFalpha and 20 U/mL IFNgamma already increased significantly the rate of apoptosis in HOMC by 1.5 fold, but the effect increased with dose up of 250 U/mL TNFalpha and 300 U/mL IFNgamma, which were used if not otherwise specified. The antiapoptotic polymeric nanomedicine, PGA-peptoid QM56, is the result of the conjugation of a novel Apaf-1 inhibitor (peptoid 1) to poly-L-glutamic acid (PGA) [30], [31]. The initial dose range was chosen based on published dose-response curves and dose-response studies in human mesothelial cells induced to undergo apoptosis by exposure to staurosporin (Figure S1) [30], [31]. Additional dose-response studies were performed in HOMC exposed to IFNgamma and TNFalpha and the concentration chosen for the rest of the studies was 10 microM. The dose of caspase inhibitors was based on previous dose-response studies [66], [67]. In addition dose-response studies were performed in HOMC exposed to IFNgamma and TNFalpha and the concentration chosen for the rest of the studies was 200 microM zVAD.
###end p 53
###begin title 54
Studies of cell death and cleavage by caspases
###end title 54
###begin p 55
###xml 214 218 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan2">[24]</xref>
###xml 220 224 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo2">[68]</xref>
Mesothelial cells were cultured to subconfluence in twelve-well plates and rested in serum-free media for 24 h. Then, IFNgamma and/or TNFalpha were added. Cells were preincubated with apoptosis inhibitors for 1 h. [24], [68].
###end p 55
###begin p 56
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Ortiz3">[22]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lorz1">[65]</xref>
###xml 861 864 861 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Santamaria1">[7]</xref>
###xml 866 870 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Guillermet1">[69]</xref>
Apoptosis was assessed by functional and morphological studies. Cell DNA content was quantified by flow cytometry in permeabilized, propidium iodide-stained cells [22], [65]. Permeabilization allows entry of propidium iodide in all cells, dead and alive. Apoptotic cells are characterized by a lower DNA content (hypodiploid cells) because of nuclear fragmentation. Caspases are key effectors of apoptosis. Evidence of caspase activation was assessed studying caspase processing by Western blot. In addition, flow cytometry or microscopy was used to quantify the appearance of a specific epitope generated by caspase cleavage of cytokeratin 18 and identified by the M30 cytodeath antibody (Roche Biochemicals, Mannheim, Germany). This epitope is generated only in epithelial and mesothelial cells, not in leukocytes, and is not present in native cytokeratin 18 [7], [69].
###end p 56
###begin p 57
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Lorz1">[65]</xref>
For morphologic assessment of apoptosis, cells were cultured in chamber slides (Labtek, Nunc, Naperville, IL), fixed with methanol:acetone (1:1), and stained with DAPI [65], or FITC-M30 cytodeath (1:250 Roche) and propidium iodide. Thus, the typical condensed, shrunk and fragmented nuclei of apoptotic cells were identified
###end p 57
###begin p 58
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo1">[29]</xref>
Trypan blue staining of freshly collected cells was used to assess cell death due to either apoptosis or necrosis [29].
###end p 58
###begin title 59
Caspase-3 activity
###end title 59
###begin p 60
###xml 606 610 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan4">[70]</xref>
HOMC were preincubated with Apaf-1 inhibitor or vehicle and cultured with IFNgamma and TNFalpha for 24 hours. Caspase-3 activity (MBL, Japan) was measured following the manufacturer's instructions. In brief, cell extracts (100 microg of protein) were incubated in half-area 96-well plates at 37degreesC with 200 microM DEVD-pNA peptide in a total volume of 100 microl. The pNA light emission was quantified using a spectrophotometer plate reader at 405 nm. Comparison of the absorbance of pNA from an apoptotic sample with an uninduced control allows determination of the fold increase in caspase activity [70].
###end p 60
###begin title 61
Wound healing
###end title 61
###begin p 62
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Yung1">[71]</xref>
The wound-healing model was modified from Yung et al. [71]. Mesothelial cells were cultured to confluence in twelve-well plates and rested in serum-free media for 24 h. The monolayer was injured with a sterile pipette tip and IFNgamma, TNFalpha and apoptosis inhibitors were added to serum-free media. Remesothelization was followed for up to 48 h by marking the injured area and counting cells inside it at different time points.
###end p 62
###begin title 63
Long-term recovery
###end title 63
###begin p 64
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Justo3">[72]</xref>
Long-term recovery was assessed by a modification of the colony-forming assay. Cells in twelve-well plates were exposed to cytokines and apoptosis inhibitor or vehicle for 24-48 h in serum-free media and then trypsinized, washed, and seeded in Petri dishes in the presence of complete medium with 20% FCS and without cytokines or inhibitors of apoptosis. Cell number was estimated at 5 days by crystal violet staining, absorbance was measured at 550 nm [72].
###end p 64
###begin title 65
Animal model
###end title 65
###begin p 66
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">Mice</span>
C57BL/6 mice, 3 month-old, were injected ip with a single dose of 300 U/mL IFNgamma and 250 ng/mL TNFalpha, or 0.5 ml PBS. QM56 (10 microM drug-equiv.) or vehicle (0.5 ml PBS) were administered 1 h before and 5 h later (total 4 groups, 5 mice per group). Mice were sacrificed at 48 h. The dose and timing were based on cell culture results.
###end p 66
###begin p 67
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006634-Catalan3">[25]</xref>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 261 270 261 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 389 398 389 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 261 270 <span type="species:ncbi:1280">S. aureus</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 389 398 <span type="species:ncbi:1280">S. aureus</span>
Staphylococcus aureus ATCC 25923 (American Type Culture Collection, Manassas, VA, USA) was used to induce peritonitis. The experimental protocol was described previously [25] C57BL/6 mice, 3 month-old were injected i.p. with 5x108 colony forming units (c.f.u.) S. aureus in 1 mL PBS or with PBS. At 48 hours mice were sacrificed. Peritonitis was mild and animals had spontaneously cleared S. aureus by 48 h.
###end p 67
###begin p 68
In both models mesenteric windows were placed on glass slides and stained with Cytodeath and propidium iodide. Studies were conducted in accord with the NIH Guide for the Care and Use of Laboratory Animals.
###end p 68
###begin title 69
Statistics
###end title 69
###begin p 70
Statistical analysis was performed using SPSS 11.0 statistical software. Results are expressed as mean+/-SEM. Significance at the p<0.05 level was assessed by Student's t test and one- way ANOVA with Bonferroni's correction or Mann-Whitney and Kruskal-Wallis tests.
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
Quantification of apoptosis in HPMC by flow cytometryof DNA content. HPMC were preincubated with QM56 for 1 hour and cultured with 100 nM staurosporin(STS) for 24 hours. * p<0.001 vscontrol (co) or different concentrations of inhibitor. Mean+/-semof 4 different experiments.
###end p 72
###begin p 73
(0.33 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
We thank Maria M. Gonzalez Garcia-Parreno for assistance with confocal microscopy, Prof Angel Messeguer for the synthesis of the peptoid inhibitors of Apaf-1 and Susana Carrasco for technical assistance.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
Apparatus for peritoneal dialysis.
###end article-title 77
###begin article-title 78
Peritoneal dialysis-related infections recommendations: 2005 update.
###end article-title 78
###begin article-title 79
Atlas of peritoneal histology.
###end article-title 79
###begin article-title 80
Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.
###end article-title 80
###begin article-title 81
###xml 18 23 <span type="species:ncbi:9606">human</span>
TNF-alpha renders human peritoneal mesothelial cells sensitive to anti-Fas antibody-induced apoptosis.
###end article-title 81
###begin article-title 82
###xml 47 52 <span type="species:ncbi:9606">human</span>
Regulation of apoptosis by lethal cytokines in human mesothelial cells.
###end article-title 82
###begin article-title 83
3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
###end article-title 83
###begin article-title 84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.
###end article-title 84
###begin article-title 85
Will modulation of cell death increase PD technique survival?
###end article-title 85
###begin article-title 86
Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution.
###end article-title 86
###begin article-title 87
###xml 28 33 <span type="species:ncbi:9606">human</span>
Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction.
###end article-title 87
###begin article-title 88
A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis.
###end article-title 88
###begin article-title 89
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 40 46 <span type="species:ncbi:9986">rabbit</span>
Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species.
###end article-title 89
###begin article-title 90
Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.
###end article-title 90
###begin article-title 91
Connective tissue growth factor is responsible for transforming growth factor-beta-induced peritoneal mesothelial cell apoptosis.
###end article-title 91
###begin article-title 92
Cytotoxicity of mononuclear cells as induced by peritoneal dialysis fluids: insight into mechanisms that regulate osmotic stress-related apoptosis.
###end article-title 92
###begin article-title 93
###xml 48 53 <span type="species:ncbi:9606">human</span>
3,4-dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells.
###end article-title 93
###begin article-title 94
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells.
###end article-title 94
###begin article-title 95
Nephrology forum: apoptotic regulatory proteins in renal injury.
###end article-title 95
###begin article-title 96
Mechanisms of renal apoptosis in health and disease.
###end article-title 96
###begin article-title 97
Apoptosis signaling.
###end article-title 97
###begin article-title 98
Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure.
###end article-title 98
###begin article-title 99
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
###end article-title 99
###begin article-title 100
Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases.
###end article-title 100
###begin article-title 101
Inhibition of caspases improves bacterial clearance in experimental peritonitis.
###end article-title 101
###begin article-title 102
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Role of caspase-8 in hepatocyte response to infection and injury in mice.
###end article-title 102
###begin article-title 103
Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells.
###end article-title 103
###begin article-title 104
Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization.
###end article-title 104
###begin article-title 105
Cytokine cooperation in renal tubular cell injury: the role of TWEAK.
###end article-title 105
###begin article-title 106
Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis.
###end article-title 106
###begin article-title 107
Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine.
###end article-title 107
###begin article-title 108
DEDD regulates degradation of intermediate filaments during apoptosis.
###end article-title 108
###begin article-title 109
Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis.
###end article-title 109
###begin article-title 110
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
###end article-title 110
###begin article-title 111
An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism.
###end article-title 111
###begin article-title 112
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.
###end article-title 112
###begin article-title 113
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation.
###end article-title 113
###begin article-title 114
Infections associated with tumor necrosis factor-alpha antagonists.
###end article-title 114
###begin article-title 115
Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity.
###end article-title 115
###begin article-title 116
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.
###end article-title 116
###begin article-title 117
The Jekyll and Hyde functions of caspases.
###end article-title 117
###begin article-title 118
In vitro model of "wound healing" analyzed by laser scanning cytometry: accelerated healing of epithelial cell monolayers in the presence of hyaluronate.
###end article-title 118
###begin article-title 119
DRONC coordinates cell death and compensatory proliferation.
###end article-title 119
###begin article-title 120
###xml 30 40 <span type="species:ncbi:7227">Drosophila</span>
Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity.
###end article-title 120
###begin article-title 121
Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury.
###end article-title 121
###begin article-title 122
Mechanisms of hepatic toxicity. I. TNF-induced liver injury.
###end article-title 122
###begin article-title 123
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
###end article-title 123
###begin article-title 124
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Tumor necrosis factor primes hepatocytes for DNA replication in the rat.
###end article-title 124
###begin article-title 125
A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint.
###end article-title 125
###begin article-title 126
Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injury.
###end article-title 126
###begin article-title 127
Real-time monitoring full length bid interacting with Bax during TNF-alpha-induced apoptosis.
###end article-title 127
###begin article-title 128
Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
###end article-title 128
###begin article-title 129
Death receptors: signaling and modulation.
###end article-title 129
###begin article-title 130
Apoptosome: a platform for the activation of initiator caspases.
###end article-title 130
###begin article-title 131
Portrait of a killer: the mitochondrial apoptosome emerges from the shadows.
###end article-title 131
###begin article-title 132
Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis.
###end article-title 132
###begin article-title 133
Basal caspase activity promotes migration and invasiveness in glioblastoma cells.
###end article-title 133
###begin article-title 134
Nonapoptotic role for Apaf-1 in the DNA damage checkpoint.
###end article-title 134
###begin article-title 135
Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development.
###end article-title 135
###begin article-title 136
Apaf1 is required for mitochondrial pathways of apoptosis and brain development.
###end article-title 136
###begin article-title 137
Cecal ligation and puncture.
###end article-title 137
###begin article-title 138
Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters.
###end article-title 138
###begin article-title 139
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.
###end article-title 139
###begin article-title 140
###xml 43 48 <span type="species:ncbi:9606">human</span>
Isolation, culture and characterization of human peritoneal mesothelial cells.
###end article-title 140
###begin article-title 141
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli.
###end article-title 141
###begin article-title 142
Paracetamol-induced renal tubular injury: a role for ER stress.
###end article-title 142
###begin article-title 143
###xml 36 42 <span type="species:ncbi:10090">murine</span>
Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases.
###end article-title 143
###begin article-title 144
Lethal activity of FADD death domain in renal tubular epithelial cells.
###end article-title 144
###begin article-title 145
###xml 43 48 <span type="species:ncbi:9606">human</span>
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
###end article-title 145
###begin article-title 146
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.
###end article-title 146
###begin article-title 147
###xml 16 21 <span type="species:ncbi:9606">human</span>
Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing.
###end article-title 147
###begin article-title 148
Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis.
###end article-title 148
###begin article-title 149
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.
###end article-title 149
###begin article-title 150
Selective activation of caspases during apoptotic induction in HL-60 cells. Effects Of a tetrapeptide inhibitor.
###end article-title 150
###begin p 151
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Research grants from Fresenius Medical care and Baxter Healthcare have gone to Alberto Ortiz and Rafael Selgas. Research grants from Gambro have gone to Rafael Selgas.
###end p 151
###begin p 152
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Grant support: ISCIII (01/0199, 06/0046, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006, Sociedad Espanola de Nefrologi-a, and Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM to AO, MEC (BIO2004-998 and BIO2007-60066) to EPP, MEC (CTQ2007-60601) and GVA (GV07/070) to MJV. BS and ACU were supported by Fundacion Conchita Rabago and AB by Fondo de Investigaciones Sanitarias (FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 152

